$HAE
HAEMONETICS CORP

2014 Q4 Form 10-Q Financial Statement

#000031314315000013 Filed on February 05, 2015

View on sec.gov

Income Statement

Concept 2014 Q4 2013 Q4
Revenue $231.8M $242.1M
YoY Change -4.25% -2.13%
Cost Of Revenue $120.2M $120.5M
YoY Change -0.27% -10.27%
Gross Profit $111.7M $121.6M
YoY Change -8.2% 7.53%
Gross Profit Margin 48.17% 50.24%
Selling, General & Admin $82.51M $89.56M
YoY Change -7.87% 3.2%
% of Gross Profit 73.9% 73.63%
Research & Development $10.64M $14.21M
YoY Change -25.1% 34.2%
% of Gross Profit 9.53% 11.68%
Depreciation & Amortization $22.30M $20.80M
YoY Change 7.21% 14.92%
% of Gross Profit 19.97% 17.1%
Operating Expenses $93.40M $103.8M
YoY Change -9.99% 6.57%
Operating Profit $18.26M $17.55M
YoY Change 4.02% 11.48%
Interest Expense -$2.300M -$2.900M
YoY Change -20.69% 16.0%
% of Operating Profit -12.6% -16.52%
Other Income/Expense, Net -$2.308M -$2.852M
YoY Change -19.07% 12.2%
Pretax Income $15.95M $15.01M
YoY Change 6.29% 13.65%
Income Tax -$36.00K -$1.282M
% Of Pretax Income -0.23% -8.54%
Net Earnings $15.99M $16.29M
YoY Change -1.85% 64.48%
Net Earnings / Revenue 6.9% 6.73%
Basic Earnings Per Share $0.31 $0.31
Diluted Earnings Per Share $0.31 $0.31
COMMON SHARES
Basic Shares Outstanding 51.43M shares 51.73M shares
Diluted Shares Outstanding 51.96M shares 52.51M shares

Balance Sheet

Concept 2014 Q4 2013 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $125.2M $177.8M
YoY Change -29.58% -7.97%
Cash & Equivalents $125.2M $177.8M
Short-Term Investments
Other Short-Term Assets $68.50M $66.60M
YoY Change 2.85% 14.24%
Inventory $212.5M $209.3M
Prepaid Expenses
Receivables $143.6M $149.6M
Other Receivables $0.00 $0.00
Total Short-Term Assets $549.8M $603.3M
YoY Change -8.87% 0.74%
LONG-TERM ASSETS
Property, Plant & Equipment $323.5M $260.1M
YoY Change 24.37% -1.15%
Goodwill $335.0M $337.0M
YoY Change -0.6% 4.9%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $13.58M $10.39M
YoY Change 30.72% -37.61%
Total Long-Term Assets $924.3M $884.6M
YoY Change 4.49% 1.04%
TOTAL ASSETS
Total Short-Term Assets $549.8M $603.3M
Total Long-Term Assets $924.3M $884.6M
Total Assets $1.474B $1.488B
YoY Change -0.92% 0.92%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $46.83M $43.11M
YoY Change 8.64% -18.79%
Accrued Expenses $48.00M $44.60M
YoY Change 7.62% 9.05%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $7.748M $40.81M
YoY Change -81.01% 187.46%
Total Short-Term Liabilities $164.3M $189.0M
YoY Change -13.05% 6.42%
LONG-TERM LIABILITIES
Long-Term Debt $421.0M $406.4M
YoY Change 3.59% -13.2%
Other Long-Term Liabilities $29.02M $37.58M
YoY Change -22.78% 57.53%
Total Long-Term Liabilities $450.0M $444.0M
YoY Change 1.36% -9.78%
TOTAL LIABILITIES
Total Short-Term Liabilities $164.3M $189.0M
Total Long-Term Liabilities $450.0M $444.0M
Total Liabilities $614.4M $633.0M
YoY Change -2.95% -5.48%
SHAREHOLDERS EQUITY
Retained Earnings $423.6M $423.2M
YoY Change 0.09% 3.32%
Common Stock $417.9M $397.1M
YoY Change 5.24% 9.49%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $833.9M $825.2M
YoY Change
Total Liabilities & Shareholders Equity $1.474B $1.488B
YoY Change -0.92% 0.92%

Cashflow Statement

Concept 2014 Q4 2013 Q4
OPERATING ACTIVITIES
Net Income $15.99M $16.29M
YoY Change -1.85% 64.48%
Depreciation, Depletion And Amortization $22.30M $20.80M
YoY Change 7.21% 14.92%
Cash From Operating Activities $26.90M $45.30M
YoY Change -40.62% 89.54%
INVESTING ACTIVITIES
Capital Expenditures -$29.60M -$15.50M
YoY Change 90.97% 1.31%
Acquisitions
YoY Change
Other Investing Activities $0.00 -$100.0K
YoY Change -100.0% -111.11%
Cash From Investing Activities -$29.60M -$15.60M
YoY Change 89.74% 9.09%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -200.0K -10.80M
YoY Change -98.15% 184.21%
NET CHANGE
Cash From Operating Activities 26.90M 45.30M
Cash From Investing Activities -29.60M -15.60M
Cash From Financing Activities -200.0K -10.80M
Net Change In Cash -2.900M 18.90M
YoY Change -115.34% 225.86%
FREE CASH FLOW
Cash From Operating Activities $26.90M $45.30M
Capital Expenditures -$29.60M -$15.50M
Free Cash Flow $56.50M $60.80M
YoY Change -7.07% 55.1%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-28
dei Document Period End Date
DocumentPeriodEndDate
2014-12-27
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0000313143
CY2014Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
51491568 shares
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
HAEMONETICS CORP
CY2014Q4 hae Capitalized Software Development Costs Placedinto Service
CapitalizedSoftwareDevelopmentCostsPlacedintoService
12900000 USD
hae Employee Stock Purchase Plan Espp Weighted Average Purchase Price Of Shares Purchased
EmployeeStockPurchasePlanESPPWeightedAveragePurchasePriceOfSharesPurchased
32.77
hae Employee Stock Purchase Plan Espp Weighted Average Purchase Price Of Shares Purchased
EmployeeStockPurchasePlanESPPWeightedAveragePurchasePriceOfSharesPurchased
25.92
hae Percentage Of Net Sales Generated Outside Of Us
PercentageOfNetSalesGeneratedOutsideOfUs
0.459
hae Restructuringand Related Cost Expected Cost Payablein Cash
RestructuringandRelatedCostExpectedCostPayableinCash
59000000 USD
CY2013Q4 hae Restructuringand Transformation Costs
RestructuringandTransformationCosts
17500000 USD
hae Restructuringand Transformation Costs
RestructuringandTransformationCosts
69889000 USD
CY2014Q4 hae Restructuringand Transformation Costs
RestructuringandTransformationCosts
12909000 USD
hae Restructuringand Transformation Costs
RestructuringandTransformationCosts
51247000 USD
CY2014 hae Term Of Each Quarter
TermOfEachQuarter
P91D
hae Term Of Each Quarter
TermOfEachQuarter
P91D
hae Transfers From Inventory To Fixed Assets
TransfersFromInventoryToFixedAssets
7967000 USD
hae Transfers From Inventory To Fixed Assets
TransfersFromInventoryToFixedAssets
5755000 USD
CY2013Q4 hae Transformation Costs
TransformationCosts
6995000 USD
hae Transformation Costs
TransformationCosts
29123000 USD
CY2014Q4 hae Transformation Costs
TransformationCosts
6714000 USD
hae Transformation Costs
TransformationCosts
22117000 USD
CY2014Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
53562000 USD
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
46830000 USD
CY2014Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
164603000 USD
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
143635000 USD
CY2014Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
3113000 USD
CY2014Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
2754000 USD
CY2014Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1410000 USD
CY2014Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-7575000 USD
CY2013Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1300000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
900000 shares
CY2014Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1700000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1600000 shares
us-gaap Asset Impairment Charges
AssetImpairmentCharges
1711000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
1246000 USD
CY2014Q1 us-gaap Assets
Assets
1514178000 USD
CY2014Q4 us-gaap Assets
Assets
1474145000 USD
CY2014Q1 us-gaap Assets Current
AssetsCurrent
622976000 USD
CY2014Q4 us-gaap Assets Current
AssetsCurrent
549831000 USD
CY2014Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
402611000 USD
CY2014Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
417405000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9664000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10219000 USD
CY2014Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1676000 USD
CY2014Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1975000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1170000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
797000 USD
CY2014Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
81804000 USD
us-gaap Average Remaining Maturity Of Foreign Currency Derivatives1
AverageRemainingMaturityOfForeignCurrencyDerivatives1
P1Y
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
1182000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
706000 USD
CY2014Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
8351000 USD
CY2014Q1 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
31700000 USD
CY2014Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
38300000 USD
CY2014Q1 us-gaap Capitalized Software Development Costs For Software Sold To Customers
CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers
15600000 USD
CY2014Q4 us-gaap Capitalized Software Development Costs For Software Sold To Customers
CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers
8900000 USD
CY2013Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
179120000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
177846000 USD
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
192469000 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
125200000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1274000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-67269000 USD
us-gaap Cash Flow Hedge Gain Loss To Be Reclassified Within Twelve Months
CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths
8400000 USD
CY2014Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2014Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2014Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
52041189 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
51491568 shares
CY2014Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
52041189 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
51491568 shares
CY2014Q1 us-gaap Common Stock Value
CommonStockValue
520000 USD
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
515000 USD
CY2013Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
17289000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.2245
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-501000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
24463000 USD
CY2014Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
8346000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
10841000 USD
CY2013Q4 us-gaap Cost Of Goods Sold
CostOfGoodsSold
120491000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
344494000 USD
CY2014Q4 us-gaap Cost Of Goods Sold
CostOfGoodsSold
120166000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
357842000 USD
CY2014Q1 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
14144000 USD
CY2014Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
16172000 USD
CY2014Q1 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
1184000 USD
CY2014Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
1031000 USD
us-gaap Deferred Tax Expense From Stock Options Exercised
DeferredTaxExpenseFromStockOptionsExercised
2906000 USD
us-gaap Deferred Tax Expense From Stock Options Exercised
DeferredTaxExpenseFromStockOptionsExercised
961000 USD
CY2014Q1 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
29664000 USD
CY2014Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
25871000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
59063000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
63891000 USD
CY2014Q1 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
3824000 USD
CY2014Q4 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
8929000 USD
CY2014Q1 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
1255000 USD
CY2014Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
2465000 USD
CY2013Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.31
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.48
CY2014Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.31
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.38
CY2013Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.31
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.48
CY2014Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.31
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.38
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
363000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-3321000 USD
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.063
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.078
CY2014Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
54913000 USD
CY2014Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
48028000 USD
CY2014Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
29000000 USD
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y7M10D
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
3200000 USD
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
3300000 USD
us-gaap Employee Stock Ownership Plan Esop Cash Contributions To Esop
EmployeeStockOwnershipPlanESOPCashContributionsToESOP
5229000 USD
us-gaap Employee Stock Ownership Plan Esop Cash Contributions To Esop
EmployeeStockOwnershipPlanESOPCashContributionsToESOP
4763000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
2076000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
0 USD
CY2014Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
101694000 USD
CY2014Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
125642000 USD
CY2014Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
271159000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0130
CY2014Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
251221000 USD
CY2014 us-gaap Fiscal Period Duration
FiscalPeriodDuration
P364D
us-gaap Fiscal Period Duration
FiscalPeriodDuration
P364D
CY2013Q4 us-gaap Gross Profit
GrossProfit
121629000 USD
us-gaap Gross Profit
GrossProfit
352924000 USD
CY2014Q4 us-gaap Gross Profit
GrossProfit
111661000 USD
us-gaap Gross Profit
GrossProfit
326053000 USD
CY2013Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
15008000 USD
CY2014Q1 us-gaap Foreign Currency Cash Flow Hedge Derivative At Fair Value Net
ForeignCurrencyCashFlowHedgeDerivativeAtFairValueNet
157900000 USD
CY2014Q4 us-gaap Foreign Currency Cash Flow Hedge Derivative At Fair Value Net
ForeignCurrencyCashFlowHedgeDerivativeAtFairValueNet
147400000 USD
CY2014Q4 us-gaap Foreign Currency Contract Asset Fair Value Disclosure
ForeignCurrencyContractAssetFairValueDisclosure
8088000 USD
CY2014Q4 us-gaap Foreign Currency Contracts Liability Fair Value Disclosure
ForeignCurrencyContractsLiabilityFairValueDisclosure
2465000 USD
CY2014Q1 us-gaap Foreign Currency Derivative Instruments Not Designated As Hedging Instruments At Fair Value Net
ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAtFairValueNet
72900000 USD
CY2014Q4 us-gaap Foreign Currency Derivative Instruments Not Designated As Hedging Instruments At Fair Value Net
ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAtFairValueNet
60400000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-612000 USD
CY2014Q1 us-gaap Goodwill
Goodwill
336768000 USD
CY2014Q4 us-gaap Goodwill
Goodwill
334990000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1679000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
4093000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
10727000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-15928000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
26646000 USD
CY2014Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
15952000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
21506000 USD
CY2013Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1282000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1682000 USD
CY2014Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-36000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-5326000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-20432000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-14422000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
24627000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
17906000 USD
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-5219000 USD
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
18834000 USD
us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
2124000 USD
us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
219000 USD
us-gaap Interest Paid Net
InterestPaidNet
6973000 USD
us-gaap Interest Paid Net
InterestPaidNet
6271000 USD
CY2014Q4 us-gaap Interest Rate Derivative Assets At Fair Value
InterestRateDerivativeAssetsAtFairValue
841000 USD
CY2014Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
117770000 USD
CY2014Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
131507000 USD
CY2014Q1 us-gaap Inventory Net
InventoryNet
197661000 USD
CY2014Q4 us-gaap Inventory Net
InventoryNet
212493000 USD
CY2014Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
72508000 USD
CY2014Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
74555000 USD
CY2014Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
7383000 USD
CY2014Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
6431000 USD
CY2014Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
72875000 USD
CY2014Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1514178000 USD
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1474145000 USD
CY2014Q1 us-gaap Liabilities Current
LiabilitiesCurrent
216928000 USD
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
164340000 USD
CY2014Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
10816000 USD
CY2014Q4 us-gaap Long Term Debt
LongTermDebt
429406000 USD
CY2014Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
45630000 USD
CY2014Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
7748000 USD
CY2014Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
0 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0175
CY2013Q4 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
242120000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
697418000 USD
CY2014Q4 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
231827000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
683895000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
CY2014Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
320327000 USD
CY2014Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
45054000 USD
CY2014Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
42683000 USD
CY2014Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
21342000 USD
CY2014Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
392057000 USD
CY2014Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
421006000 USD
CY2014Q4 us-gaap Loss Contingency Estimate Of Possible Loss
LossContingencyEstimateOfPossibleLoss
4100000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-14668000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-35678000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-75022000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-100143000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
88053000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
71873000 USD
CY2013Q4 us-gaap Net Income Loss
NetIncomeLoss
16290000 USD
us-gaap Net Income Loss
NetIncomeLoss
24964000 USD
CY2014Q4 us-gaap Net Income Loss
NetIncomeLoss
15988000 USD
us-gaap Net Income Loss
NetIncomeLoss
19827000 USD
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2013Q4 us-gaap Operating Expenses
OperatingExpenses
103769000 USD
us-gaap Operating Expenses
OperatingExpenses
318243000 USD
CY2014Q4 us-gaap Operating Expenses
OperatingExpenses
93401000 USD
us-gaap Operating Expenses
OperatingExpenses
297051000 USD
CY2013Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
17860000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
34681000 USD
CY2014Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
18260000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
29002000 USD
CY2014Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
10654000 USD
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
13581000 USD
us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-6064000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-8985000 USD
CY2014Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
59710000 USD
CY2014Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
58980000 USD
CY2014Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
37641000 USD
CY2014Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
29020000 USD
CY2013Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2852000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-8035000 USD
CY2014Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2308000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-7496000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
8374000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
0 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
38701000 USD
us-gaap Payments For Restructuring
PaymentsForRestructuring
19256000 USD
us-gaap Payments For Restructuring
PaymentsForRestructuring
34312000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
23124000 USD
CY2013Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
89560000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
277879000 USD
CY2014Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
82758000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
260089000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
10.17
us-gaap Payments To Acquire In Process Research And Development
PaymentsToAcquireInProcessResearchAndDevelopment
-3569000 USD
us-gaap Payments To Acquire In Process Research And Development
PaymentsToAcquireInProcessResearchAndDevelopment
0 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
43721000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
100530000 USD
CY2014Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
54099000 USD
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
52331000 USD
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-4426000 USD
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-357000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
197000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
387000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
11699000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
7926000 USD
CY2013Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
673000 USD
CY2013Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
709000 USD
CY2014Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
590000 USD
CY2014Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
539000 USD
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
1178000 USD
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
941000 USD
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
1214000 USD
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
890000 USD
CY2014Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
271437000 USD
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
323491000 USD
us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
2921000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
715000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
778000 USD
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
28531000 USD
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
8531000 USD
CY2013Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14209000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
40364000 USD
CY2014Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10643000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
36962000 USD
us-gaap Research And Development Expense Software Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost
3400000 USD
us-gaap Research And Development Expense Software Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost
-6600000 USD
CY2014Q4 us-gaap Restructuring And Related Cost Expected Cost1
RestructuringAndRelatedCostExpectedCost1
69000000 USD
CY2013Q4 us-gaap Restructuring Charges
RestructuringCharges
10505000 USD
us-gaap Restructuring Charges
RestructuringCharges
40766000 USD
CY2014Q4 us-gaap Restructuring Charges
RestructuringCharges
6195000 USD
us-gaap Restructuring Charges
RestructuringCharges
29130000 USD
CY2013Q1 us-gaap Restructuring Reserve
RestructuringReserve
3262000 USD
CY2013Q4 us-gaap Restructuring Reserve
RestructuringReserve
22100000 USD
CY2014Q1 us-gaap Restructuring Reserve
RestructuringReserve
23636000 USD
CY2014Q4 us-gaap Restructuring Reserve
RestructuringReserve
17001000 USD
us-gaap Restructuring Reserve Accrual Adjustment
RestructuringReserveAccrualAdjustment
-2672000 USD
us-gaap Restructuring Reserve Accrual Adjustment
RestructuringReserveAccrualAdjustment
-1453000 USD
CY2014Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
433347000 USD
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
423563000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
7.89
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y10M24D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y10M24D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.2279
us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
156224 shares
us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
183808 shares
CY2014Q1 us-gaap Stockholders Equity
StockholdersEquity
837888000 USD
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
833908000 USD
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-351000 USD
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-1477000 USD
CY2013Q4 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
781000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
815000 shares
CY2014Q4 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
530000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
503000 shares
CY2013Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52511000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52300000 shares
CY2014Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51962000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52024000 shares
CY2013Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51730000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51485000 shares
CY2014Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51432000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51521000 shares

Files In Submission

Name View Source Status
0000313143-15-000013-index-headers.html Edgar Link pending
0000313143-15-000013-index.html Edgar Link pending
0000313143-15-000013.txt Edgar Link pending
0000313143-15-000013-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
hae-20141227.xml Edgar Link completed
hae-20141227.xsd Edgar Link pending
hae-20141227_cal.xml Edgar Link unprocessable
hae-20141227_def.xml Edgar Link unprocessable
hae-20141227_lab.xml Edgar Link unprocessable
hae-20141227_pre.xml Edgar Link unprocessable
haeq3dec201510b.htm Edgar Link pending
haeq3dec2015doc.htm Edgar Link pending
haeq3dec2015ex311.htm Edgar Link pending
haeq3dec2015ex312.htm Edgar Link pending
haeq3dec2015ex321.htm Edgar Link pending
haeq3dec2015ex322.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending